Sign up for the Freshfields TQ digest
MedTech
MedTech M&A, Strategic MedTech Collaborations
The combination of rapid technological innovation and disruption of traditional models of care has accelerated the integration of MedTech offerings in healthcare.
Our global MedTech practice is a core component of the firm’s life sciences group. Our team combines the world’s leading M&A, capital markets and antitrust attorneys with deep life sciences, technology and MedTech expertise. Through a cross-disciplinary approach, we advise our MedTech clients, including life sciences businesses, technology firms, healthcare companies and providers, and investors, on their most critical and complex M&A, joint venture, licence, collaboration, capital markets and other strategic transactions. Our MedTech expertise spans medical devices (including SaMD) as well as a range of digital health and health IT products, services and platforms.
Our MedTech insights
Blogs
Podcasts
Our MedTech experience
Agilent Technologies, Inc. on its acquisition of e-MSion, Inc., an early-stage company behind the innovative electron capture dissociation technology known as the ExD cell.
A digital health solutions provider on its acquisition of a majority of shares of a company that develops patient portals and apps for a variety of healthcare facilities.
Berkeley Lights, a life sciences tools company, on its acquisition of IsoPlexis. The combination formed a premier functional cell biology company called PhenomeX (Nasdaq: CELL).
CVC Capital Partners on its investment in Spectrum Medical, a healthcare systems provider focusing on non-invasive diagnostic blood monitoring technology.
Equita Smart Capital on its acquisition of a minority stake in Clonit, an infectious diseases and genetic diseases molecular testing company.
Excelra, a global life science focused data analytics company, on the acquisition of BISC Global, one of the top bioinformatic services providers supporting the world’s leading pharmaceutical and biotech companies.
General Atlantic on its investment in the Series B funding round of Reliance Health, Inc., an emerging-markets-focused digital healthcare provider primarily based in Nigeria.
Luminex Corporation on the sale of its global Flow Cytometry & Imaging business unit to Cytek Biosciences, Inc.
Rayner Surgical on its acquisition of the product OMIDRIA® from Omeros Corporation in a transaction valued in excess of $1 billion
The innovation team of a leading healthcare provider on strategic technology and IP investments and transactions, including transactions involving novel SaMD, AI/ML and data analytic tools to improve healthcare delivery and outcomes.
Two investment holding companies in a co-investment in a medtech company focusing on molecular diagnostics.
Veterinary diagnostic services provider on the acquisition of a medical technology company
Zymergen on its $300m sale to Ginkgo Bioworks--the first-ever sale of a publicly-listed public benefit corporation.
Our MedTech team
Vinita Kailasanath 合伙人
Silicon Valley
Dr. Philipp Dohnke 合伙人
Hamburg
Giles Pratt 合伙人
London
Dr. Christoph Werkmeister 合伙人
Düsseldorf
Sharon Malhi Partner, Antitrust Competition and Trade
London, Dublin
Rod Carlton 合伙人
London, Brussels
Menachem Kaplan 合伙人
New York
Dr. Michael Ramb 合伙人
Berlin
Timothy Harkness 合伙人
New York
